Comparative treatment effectiveness of direct acting antiviral regimens for hepatitis C: Data from the Veterans administration (Q31143582)

29 June 2017

title

Comparative treatment effectiveness of direct acting antiviral regimens for hepatitis C: Data from the Veterans administration (English)

1 reference

29 June 2017

0 references

D Steven Fox

1 reference

29 June 2017

Justin J McGinnis

series ordinal

1 reference

29 June 2017

Ivy Q Tonnu-Mihara

series ordinal

1 reference

29 June 2017

Jeffrey S McCombs

series ordinal

1 reference

29 June 2017

publication date

21 November 2016

1 reference

Journal of Gastroenterology and Hepatology

29 June 2017

published in

1 reference

29 June 2017

1 reference

29 June 2017

1 reference

29 June 2017

page(s)

1136-1142

1 reference

The global burden of hepatitis C

29 June 2017

cites work

1 reference

The natural history of hepatitis C virus (HCV) infection

21 January 2018

1 reference

The history of the "natural history" of hepatitis C (1968-2009).

21 January 2018

1 reference

Evolving epidemiology of hepatitis C virus in the United States

21 January 2018

1 reference

Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010

21 January 2018

1 reference

Elevated prevalence of hepatitis C infection in users of United States veterans medical centers

21 January 2018

1 reference

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study

21 January 2018

1 reference

Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection

21 January 2018

1 reference

Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection

21 January 2018

1 reference

Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis

21 January 2018

1 reference

Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin

21 January 2018

1 reference

Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin

21 January 2018

1 reference

ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis

21 January 2018

1 reference

Sofosbuvir-based regimens in clinical practice achieve SVR rates closer to clinical trials: results from ERCHIVES.

21 January 2018

1 reference

Safety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal function.

21 January 2018

1 reference

Comparative effectiveness of ledipasvir/sofosbuvir ± ribavirin vs. ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in 6961 genotype 1 patients treated in routine medical practice.

21 January 2018

1 reference

Real-world effectiveness of ledipasvir/sofosbuvir in 4,365 treatment-naive, genotype 1 hepatitis C-infected patients

21 January 2018

1 reference

Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System

21 January 2018

1 reference

Optimizing HCV treatment - Moving beyond the cost conundrum

21 January 2018

1 reference

Broad Hepatitis C Treatment Scenarios Return Substantial Health Gains, But Capacity Is A Concern.

21 January 2018

1 reference

Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis.

21 January 2018

1 reference

Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant

21 January 2018

1 reference

Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center "real-life" cohort

21 January 2018

1 reference

Concordance of sustained virological response 4, 12, and 24 weeks post-treatment with sofosbuvir-containing regimens for hepatitis C virus

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JGH.13652

1 reference

29 June 2017

1 reference